EFFECTS OF ATACICEPT ON DISEASE ACTIVITY IN PATIENTS WITH MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: APRIL-SLE RANDOMIZED TRIAL

被引：1

作者：

Gordon, C. ^{[1
]}

Isenberg, D. ^{[2
]}

Li, Y. ^{[3
]}

Wax, S. ^{[4
]}

Wofsy, D. ^{[5
]}

Rossi, C. Pena ^{[6
]}

机构：

[1] Univ Birmingham, Sch Immun & Infect, Rheumatol Res Grp, Birmingham, W Midlands, England

[2] UCL, Ctr Rheumatol, London, England

[3] EMD Serono Inc, R&D Global BioStat, Rockland, ME USA

[4] EMD Serono Inc, Global Clin Dev Ctr, Immunol, Rockland, ME USA

[5] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, Div Rheumatol, San Francisco, CA 94143 USA

[6] Merck Serono SA, Geneva, Switzerland

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷

关键词：

D O I：

10.1136/annrheumdis-2014-eular.4384

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OP0044

引用

页码：77 / 77

页数：1

共 1 条

[1] The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus:: A randomized trial [J].

Buyon, JP ;

Petri, MA ;

Kim, MY ;

Kalunian, KC ;

Grossman, J ;

Hahn, BH ;

Merrill, JT ;

Sammaritano, L ;

Lockshin, M ;

Alarcón, GS ;

Manzi, S ;

Belmont, HM ;

Askanase, AD ;

Sigler, L ;

Dooley, MA ;

Von Feldt, J ;

McCune, WJ ;

Friedman, A ;

Wachs, J ;

Cronin, M ;

Hearth-Holmes, M ;

Tan, M ;

Licciardi, F .

ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) :953-962

← 1 →